Cheng Pang
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
-
- Prostate Cancer Diagnosis and Treatment 4
- Ferroptosis and cancer prognosis 3
- Prostate Cancer Treatment and Research 3
-
- RNA modifications and cancer 4
-
- Bladder and Urothelial Cancer Treatments 4
- Adrenal and Paraganglionic Tumors 3
- Co-authors
- Gang ZhuHongbo LiWanqing ChenWeiwei FangMelanie HamiltonStephen CharlesRichard LeggettDavid Prime
- Partner nations
- ChinaUnited KingdomSingapore
In The Last Decade
Cheng Pang
27 papers receiving 460 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 147
- Pulmonary and Respiratory Medicine 167
- Endocrinology, Diabetes and Metabolism 51
- Molecular Biology 174
- Surgery 107
Countries citing papers authored by Cheng Pang
This map shows the geographic impact of Cheng Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Pang more than expected).
Fields of papers citing papers by Cheng Pang
This network shows the impact of papers produced by Cheng Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Pang. The network helps show where Cheng Pang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheng Pang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 4 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 5 | |
| 13 | 2019 | 9 | |
| 14 | 2019 | 3 | |
| 15 | 2019 | 6 | |
| 16 | 2018 | 32 | |
| 17 | 2016 | 125 | |
| 18 | 2015 | 46 | |
| 19 | 2012 | 21 | |
| 20 | [Intervention effects of promoting the use of contraceptives in migrant population working in factory]. | 2011 | 1 |
About Cheng Pang
Cheng Pang is a scholar working on Urology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 465 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), RNA modifications and cancer (4 papers), MicroRNA in disease regulation (3 papers), Ferroptosis and cancer prognosis (3 papers), Adrenal and Paraganglionic Tumors (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Cancer Research (147 citations), Pulmonary and Respiratory Medicine (167 citations) and Endocrinology, Diabetes and Metabolism (51 citations). Cheng Pang has collaborated with scholars based in China, United Kingdom and Singapore. Frequent co-authors include Gang Zhu, Hongbo Li, Wanqing Chen, Weiwei Fang, Melanie Hamilton, Stephen Charles, Richard Leggett, David Prime, Jun Guo and Xiuqing Huang. Their work appears in journals such as Injury, Japanese Journal of Clinical Oncology, Molecules, BMC Nephrology and Frontiers in Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.